Mucoxx

Indication:

Treatment of acute respiratory tract diseases with impaired  formation of secretions, particularly in acute exacerbation of chronic and asthmatic bronchitis, bronchial asthma and bronchiectasis. Treatment of respiratory disorders associated with viscid mucus eg, pneumonia, otitis media, sinusitis, nasopharyngitis. As secretolytic therapy for relieving cough in acute and chronic disorders of the respiratory tract associated with pathologically thickened mucus and impaired mucus transport.

Dosage & Administration:

1 capsule daily. The capsule should be swallowed whole without chewing after a meal with adequate fluid, or as prescribed by the physician.

FDA Reg. No.: DRP-2483-03